These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 1178688)

  • 1. The effect of rifampicin on dapsone metabolism.
    Gelber RH; Gool HC; Rees RJ
    Proc West Pharmacol Soc; 1975; 18():330-4. PubMed ID: 1178688
    [No Abstract]   [Full Text] [Related]  

  • 2. Dapsone metabolism in patients with dapsone-resistant leprosy.
    Gelber RH; Rees RJ
    Am J Trop Med Hyg; 1975 Nov; 24(6 Pt 1):963-7. PubMed ID: 1106232
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of clofazimine on the pharmacokinetics of rifampicin and dapsone in leprosy.
    Venkatesan K; Mathur A; Girdhar BK; Bharadwaj VP
    J Antimicrob Chemother; 1986 Dec; 18(6):715-8. PubMed ID: 3818497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dapsone acetylation in man: another example of polymorphic acetylation.
    Peters JH; Levy L
    Ann N Y Acad Sci; 1971 Jul; 179():660-6. PubMed ID: 5285396
    [No Abstract]   [Full Text] [Related]  

  • 5. Metabolic disposition of dapsone in patients with dapsone-resistant leprosy.
    Peters JH; Gordon GR; Levy L; Strokan MA; Jacobson RR; Enna CD; Kirchheimer WF
    Am J Trop Med Hyg; 1974 Mar; 23(2):222-30. PubMed ID: 4817667
    [No Abstract]   [Full Text] [Related]  

  • 6. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
    Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
    Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of rifampicin, clofazimine and dapsone in treating 296 cases of multibacillary leprosy].
    Li WZ
    Zhonghua Yi Xue Za Zhi; 1987 Jan; 67(1):1-3. PubMed ID: 3109697
    [No Abstract]   [Full Text] [Related]  

  • 8. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
    Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
    Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persister M. leprae after introductory rifampicin followed by dapsone therapy.
    Sreevatsa ; Girdhar BK; Desikan KV
    Lepr India; 1981 Jul; 53(3):350-3. PubMed ID: 7278139
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
    Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
    Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The chemotherapy of leprosy. Part 1.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined treatments consisting of rifampicin in periodic doses: the experience in Niger].
    Soga G; Blanc L; Alfa C; Grosset J; Xavier S
    Acta Leprol; 1986; 4(4):397-407. PubMed ID: 3296609
    [No Abstract]   [Full Text] [Related]  

  • 15. [Efficacy of a daily dosage of dapsone combined with a single dose of rifampicin. Clinical, bacteriological and histopathological evaluation].
    Le KD; Nguyen N; Nguyen VM
    Acta Leprol; 1981; 85():75-82. PubMed ID: 6805238
    [No Abstract]   [Full Text] [Related]  

  • 16. Intracellular localization of dapsone and rifampicin in skin and nerve of multidrug treated leprosy patients.
    Save MP; Shetty VP; Antia NH
    Indian J Lepr; 1995; 67(3):273-84. PubMed ID: 8576606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dapsone syndrome--a case report.
    Khare AK; Bansal NK; Meena HS
    Indian J Lepr; 1987; 59(1):106-9. PubMed ID: 3611856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 19. [Efficacy of combined treatments comprising 6 months' administration of rifampicin in multibacillary leprosy].
    Pattyn SR; Husser JA; Saint-André P
    Acta Leprol; 1986; 4(4):445-6. PubMed ID: 3296614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Study on drug interactions.
    Venkatesan K; Bharadwaj VP; Ramu G; Desikan KV
    Lepr India; 1980 Apr; 52(2):229-35. PubMed ID: 7453137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.